• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis
 
  • Details
  • Full
Options
2020
Journal Article
Title

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis

Author(s)
Lauer, Eliza M.
Waterhouse, Miguel
Braig, Moritz
Mutter, Jurik
Bleul, Sabine
Duque-Afonso, Jesús
Duyster, Justus
Marks, Reinhard
Reinacher, Peter Christoph  
Prinz, Marco
Illerhaus, Gerald
Finke, Jürgen
Schorb, Elisabeth
Scherer, Florian
Journal
British Journal of Haematology  
DOI
10.1111/bjh.16759
Language
English
Fraunhofer-Institut für Lasertechnik ILT  
Keyword(s)
  • BTK inhibition

  • central nervous system lymphoma

  • Ibrutinib

  • real-world analysis

  • relapsed / refractory disease

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024